Paul M. Barr, MD | Authors


Diffuse Large B-Cell Lymphoma in the Very Elderly: The Case for Refining Our Clinical Trials

February 16, 2013

Further prospective clinical trials in very elderly patients with DLBCL are clearly needed. Complementing the growing need for such trials, an evolving clinical trial infrastructure, geriatric oncology support, and novel therapeutics are making such studies feasible in the current era.